ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Market News
4 of the biggest news pieces from the ASX200 this week
Share Gainers
These were the best performing ASX 200 shares last week
Share Market News
ALL ORDINARIES finishes higher Friday: 8 ASX shares you missed
Share Gainers
Why AVITA, Bigtincan, Link, & ResMed shares are storming higher
Share Market News
ASX 200 lunch update: ANZ, Link, & ResMed higher
Share Market News
ResMed share price lifts on double-digit Q2 revenue growth
Share Market News
Top brokers name 3 ASX shares to sell right now
⏸️ ASX Shares
Where to invest $2,500 into ASX shares in February
Share Market News
This ASX healthcare share skyrocketed last week. Should you invest?
Share Market News
Leading brokers name 3 ASX shares to buy today
Growth Shares
3 ASX healthcare shares I would buy and hold for a decade
⏸️ ASX Shares
10 high quality ASX shares to buy in 2020
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
